FY2024 EPS Estimates for Danaher Lifted by Leerink Partnrs

Danaher Co. (NYSE:DHR) – Equities research analysts at Leerink Partnrs boosted their FY2024 EPS estimates for shares of Danaher in a research report issued to clients and investors on Tuesday, January 21st. Leerink Partnrs analyst P. Souda now expects that the conglomerate will post earnings of $7.52 per share for the year, up from their prior estimate of $7.49. The consensus estimate for Danaher’s current full-year earnings is $7.49 per share. Leerink Partnrs also issued estimates for Danaher’s Q4 2024 earnings at $2.18 EPS.

A number of other equities analysts have also commented on the stock. TD Cowen raised their price objective on shares of Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Guggenheim started coverage on shares of Danaher in a report on Thursday, December 19th. They issued a “buy” rating and a $275.00 price target for the company. Stephens reaffirmed an “overweight” rating and issued a $315.00 price target on shares of Danaher in a report on Wednesday, October 23rd. Stifel Nicolaus lifted their price objective on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research note on Wednesday, October 23rd. Finally, Barclays decreased their target price on Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $285.55.

Danaher Stock Up 2.4 %

Shares of NYSE DHR opened at $244.18 on Wednesday. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The company has a market cap of $176.36 billion, a P/E ratio of 46.60, a P/E/G ratio of 4.30 and a beta of 0.83. Danaher has a 52 week low of $225.42 and a 52 week high of $281.70. The business has a 50-day simple moving average of $234.75 and a two-hundred day simple moving average of $253.50.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.57 by $0.14. The company had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period in the previous year, the business earned $2.02 earnings per share.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be given a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.44%. The ex-dividend date of this dividend is Friday, December 27th. Danaher’s payout ratio is presently 20.61%.

Institutional Trading of Danaher

Institutional investors have recently added to or reduced their stakes in the business. Jamison Private Wealth Management Inc. grew its position in Danaher by 1.7% during the 4th quarter. Jamison Private Wealth Management Inc. now owns 9,756 shares of the conglomerate’s stock worth $2,239,000 after acquiring an additional 159 shares during the last quarter. First Citizens Bank & Trust Co. grew its holdings in shares of Danaher by 1.4% in the fourth quarter. First Citizens Bank & Trust Co. now owns 40,422 shares of the conglomerate’s stock worth $9,279,000 after purchasing an additional 561 shares during the last quarter. Investment Research & Advisory Group Inc. increased its stake in shares of Danaher by 3.4% in the fourth quarter. Investment Research & Advisory Group Inc. now owns 5,338 shares of the conglomerate’s stock worth $1,225,000 after buying an additional 177 shares during the period. Duncan Williams Asset Management LLC boosted its position in Danaher by 7.2% during the 4th quarter. Duncan Williams Asset Management LLC now owns 4,477 shares of the conglomerate’s stock valued at $1,028,000 after buying an additional 301 shares during the period. Finally, Affiance Financial LLC grew its holdings in Danaher by 54.4% in the 4th quarter. Affiance Financial LLC now owns 1,135 shares of the conglomerate’s stock worth $169,000 after acquiring an additional 400 shares during the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.